ConductScience.org, home

Paper33650334

Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation.

Jung J and 4 others. J Korean Med Sci, 2021. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation. Papers, record 33650334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33650334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation.
PubMed
Journal
J Korean Med Sci
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2021-10-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft vs Host DiseaseMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Whole-Body IrradiationMajor topic
Cyclophosphamide
Hematologic Neoplasms
Humans
Immunosuppressive Agents
Recurrence
Survival Rate
Transplantation, Homologous

Source PubMed

Download CSV of topics

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131394267Updated Clinical Outcomes of Hematopoietic Stem Cell Transplantation Using Myeloablative Total Body Irradiation with Ovarian Shielding to Preserve Fertility.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/31394267PubMed
223442062
Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant.
Leuk Lymphoma2013https://conductscience.org/library/papers/23442062PubMed
324315843
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients.
Biol Blood Marrow Transplant2014https://conductscience.org/library/papers/24315843PubMed
426130705Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.Blood2015https://conductscience.org/library/papers/26130705PubMed
532110285Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies.Ther Adv Hematol2020https://conductscience.org/library/papers/32110285PubMed
629893272Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).Int J Radiat Oncol Biol Phys2018https://conductscience.org/library/papers/29893272PubMed
731306219Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma.Chin Med J (Engl)2019https://conductscience.org/library/papers/31306219PubMed
830408564Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30408564PubMed
929296834Haploidentical transplant in patients with myelodysplastic syndrome.Blood Adv2017https://conductscience.org/library/papers/29296834PubMed
1030243581Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30243581PubMed
1224065243Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.Blood2013https://conductscience.org/library/papers/24065243PubMed
1317317589Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.Biol Blood Marrow Transplant2007https://conductscience.org/library/papers/17317589PubMed
142224134Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.Blood1990https://conductscience.org/library/papers/2224134PubMed
1530872371State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019.Haematologica2019https://conductscience.org/library/papers/30872371PubMed
1623370119Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.Biol Blood Marrow Transplant2013https://conductscience.org/library/papers/23370119PubMed
1730117176Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.Am J Hematol2018https://conductscience.org/library/papers/30117176PubMed
1825016195Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.Biol Blood Marrow Transplant2014https://conductscience.org/library/papers/25016195PubMed
1924747336
Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
Biol Blood Marrow Transplant2014https://conductscience.org/library/papers/24747336PubMed
2026284307HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome.Exp Hematol2015https://conductscience.org/library/papers/26284307PubMed
2128633038Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.Hematol Oncol Stem Cell Ther2017https://conductscience.org/library/papers/28633038PubMed

See all 66 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41584606Multi-isocentric volumetric arc-based total body irradiation: radiation dose impact on oncological outcomes in patients receiving allogeneic hematopoietic cell transplantation.Front Oncol2025https://conductscience.org/library/papers/41584606PubMed
41010894Total Body Irradiation in Haematopoietic Stem Cell Transplantation: A Comprehensive Literature Review and Institutional Experience from the Policlinico of Catania.Medicina (Kaunas)2025https://conductscience.org/library/papers/41010894PubMed
34912605Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?Cureus2021https://conductscience.org/library/papers/34912605PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33650334

GET https://conductscience.org/api/papers/v1/33650334/references?page=2